REGENERATIVE MEDICINE AND STEM CELL THERAPY: A COMPREHENSIVE REVIEW OF CURRENT ADVANCES AND CLINICAL APPLICATIONS
Keywords:
Regenerative medicine, stem cell therapy, induced pluripotent stem cells, mesenchymal stem cells, CAR-T therapy, tissue engineering, CRISPR gene editing, clinical trials, personalized medicine, exosome therapy.Abstract
Regenerative medicine represents one of the most transformative frontiers in modern healthcare, leveraging the body's intrinsic repair mechanisms to restore damaged tissues and organs. Stem cell therapy, as the cornerstone of this field, has evolved from experimental promise to clinical reality, with the global market projected to exceed $28 billion in 2026. This comprehensive review examines the current landscape of regenerative medicine, encompassing hematopoietic stem cell transplantation, CAR-T cell immunotherapy, induced pluripotent stem cell (iPSC) platforms, mesenchymal stem cell therapies, and emerging cell-free approaches including exosome-based treatments. We analyze recent clinical milestones, including FDA-approved therapies for sickle cell disease and beta-thalassemia through CRISPR gene editing, landmark trials in Parkinson's disease and ALS, and the expansion of CAR-T therapy into autoimmune disorders. The convergence of artificial intelligence, precision medicine, and advanced manufacturing is accelerating therapeutic development while reducing costs. However, significant challenges persist regarding scalability, long-term safety, regulatory harmonization, and equitable access to these potentially curative treatments. This article provides clinicians, researchers, and patients with an evidence-based overview of where the field stands in 2026 and the trajectory toward standard-of-care integration.
References
[1] The Business Research Company. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report 2026–2035. London, UK; March 2026.
[2] Krieger J. Stem Cell Therapy & Regenerative Medicine 2026: The Complete State-of-the-Field Guide. TopDoctor Magazine. March 24, 2026.
[3] DVC Stem. Stem Cell Research: The Future of Regenerative Medicine. 2026. Available at: https://www.dvcstem.com/post/stem-cell-research
[4] Ubie Health. New Research into Stem Cells and Nerve Regrowth for 2026. April 24, 2026.
[5] Cure. 10 Stem Cell Companies to Watch in 2026. March 30, 2026.
[6] Georgia Institute of Technology. 2026 Awardees Announced for Regenerative Engineering and Medicine Center Collaborative Seed Grant. February 11, 2026.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ideal Journal of Multidisciplinary Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
